Blood Tests for Kidney Transplant: What to Expect Before and After

A practical, clinician-informed guide to the laboratory tests that protect your kidney — from the first evaluation appointment to years of post-transplant follow-up.

Why Blood Tests Are the Backbone of Kidney Transplant Care

A kidney transplant is one of the most life-changing procedures in modern medicine — but the surgery itself is only part of the journey. Before a transplant can even be scheduled, a detailed evaluation must confirm that both donor and recipient are medically ready. After the transplant, a carefully structured schedule of blood tests becomes the primary tool for detecting rejection, infection, drug toxicity, and returning kidney disease — often weeks before any symptom appears.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), regular laboratory monitoring is a cornerstone of post-transplant management and significantly improves long-term graft survival. Understanding what each test measures — and why it matters — helps patients become active partners in their own care.

At Apex Hospitals' kidney transplant programme in Jaipur, the nephrology and transplant team uses a structured, protocol-driven approach to laboratory monitoring — from the first pre-transplant workup through long-term outpatient follow-up. This guide walks you through every key test, what it reveals, and what abnormal results might mean.

Part 1: Blood Tests Before the Transplant (Pre-Transplant Evaluation)

The pre-transplant evaluation is a comprehensive medical assessment designed to answer two questions: Is the patient healthy enough to undergo surgery and immunosuppression? And is the donor kidney a compatible match? The blood tests ordered during this phase are extensive and serve distinct purposes.

1. Blood Typing (ABO Compatibility)

The most fundamental compatibility test. Donor and recipient blood types must be compatible — ideally identical — to avoid hyperacute rejection, a severe immune reaction that can destroy the transplanted kidney within minutes of surgery. ABO-incompatible transplants are possible in specialised centres but require additional preparation.

2. HLA Typing (Human Leukocyte Antigen)

HLA typing identifies specific proteins on the surface of cells that the immune system uses to distinguish "self" from "foreign." A closer HLA match between donor and recipient reduces the risk of rejection and may allow lower doses of immunosuppressive medication over time. Six HLA antigens are typically assessed: HLA-A, B, C, DR, DQ, and DP.

3. Crossmatch Test

The crossmatch is performed by mixing the recipient's blood serum with the donor's lymphocytes. A positive crossmatch — meaning the recipient already has antibodies against the donor's cells — is generally a contraindication to transplant, as it predicts a high risk of immediate rejection. A negative crossmatch is required before proceeding.

4. Panel Reactive Antibody (PRA) Test

The PRA test measures the percentage of the general population against whose HLA antigens the recipient has pre-formed antibodies. A high PRA (above 80%) means the patient is "highly sensitised" — likely due to prior transplants, blood transfusions, or pregnancies — and will have a harder time finding a compatible donor. Highly sensitised patients may require desensitisation protocols before transplant.

5. Complete Blood Count (CBC)

A CBC evaluates red blood cells, white blood cells, and platelets. In patients with chronic kidney disease, anaemia is extremely common due to reduced erythropoietin production. The CBC helps the transplant team assess the severity of anaemia, detect infection (elevated white cell count), and check for bleeding risk (platelet count) before surgery.

6. Comprehensive Metabolic Panel (CMP)

This panel includes serum creatinine, blood urea nitrogen (BUN), electrolytes (sodium, potassium, bicarbonate, chloride), blood glucose, and liver function tests. It provides a snapshot of the recipient's current kidney function, metabolic status, and liver health — all critical for anaesthesia planning and post-operative medication dosing.

7. Infectious Disease Screening

Because immunosuppressive drugs will be used after transplant, latent infections must be identified and managed beforehand. Standard screening includes:

• HIV antibody test — active HIV is a relative contraindication; controlled HIV is increasingly accepted at specialist centres

• Hepatitis B surface antigen (HBsAg) and Hepatitis C antibody — both can reactivate under immunosuppression

• Cytomegalovirus (CMV) IgG — CMV mismatch between donor and recipient is a major risk factor for post-transplant CMV disease

• Epstein-Barr Virus (EBV) serology — EBV-naïve recipients receiving EBV-positive donor kidneys are at risk for post-transplant lymphoproliferative disorder (PTLD)

• Tuberculosis (TB) screening — especially important in Rajasthan and across India, where TB prevalence remains significant

• VDRL/RPR (syphilis)

8. Coagulation Profile

Prothrombin time (PT), activated partial thromboplastin time (aPTT), and INR are checked to assess bleeding and clotting risk before surgery. Patients on dialysis may have platelet dysfunction that is not fully captured by these tests, so clinical assessment is equally important.

9. Lipid Profile and Blood Glucose / HbA1c

Cardiovascular disease is the leading cause of death in kidney transplant recipients. A fasting lipid panel and HbA1c (to screen for diabetes or pre-diabetes) help stratify cardiovascular risk and guide pre-transplant optimisation. Post-transplant diabetes mellitus (PTDM) is a known complication of calcineurin inhibitors and steroids, so baseline glucose metabolism must be documented.

Part 2: Blood Tests After the Transplant (Post-Transplant Monitoring)

Once the transplant is complete, blood tests shift from evaluation to surveillance. The frequency is highest in the first weeks — sometimes daily — and gradually decreases as the kidney stabilises and immunosuppression is optimised. The National Kidney Foundation recommends lifelong monitoring for all transplant recipients, as rejection and complications can occur years after surgery.

1. Serum Creatinine and eGFR — The Primary Graft Function Markers

Serum creatinine is the single most important post-transplant blood test. A rising creatinine — even a 20–25% increase above baseline — is a red flag that demands urgent evaluation. Causes include acute rejection, calcineurin inhibitor toxicity, dehydration, urinary obstruction, or recurrence of the original kidney disease. Estimated GFR (eGFR) is calculated from creatinine, age, and sex, and provides a standardised measure of kidney function over time.

2. Tacrolimus (FK506) Drug Level Monitoring

Tacrolimus is the most widely used calcineurin inhibitor in kidney transplantation. Its therapeutic window is narrow: too little drug risks rejection; too much causes nephrotoxicity, neurotoxicity, and metabolic complications. Trough levels (drawn just before the next dose) are measured frequently — sometimes daily in the first weeks — and target ranges are adjusted based on time post-transplant and rejection risk. Typical targets range from 8–12 ng/mL in the early period to 4–8 ng/mL at one year.

3. Complete Blood Count (CBC) — Monitoring for Infection and Drug Effects

Post-transplant, the CBC is checked regularly to detect leucopenia (low white cell count) caused by immunosuppressive drugs such as mycophenolate mofetil (MMF) or azathioprine. Leucopenia increases infection risk and may require dose reduction. Anaemia may persist or recur, and thrombocytopenia can signal drug toxicity or viral infection (e.g., CMV).

4. Electrolytes — Potassium, Sodium, Bicarbonate, Phosphate

Tacrolimus and cyclosporine can cause hyperkalaemia (high potassium), which carries cardiac risk. Hypomagnesaemia is also common with calcineurin inhibitors and may require supplementation. Phosphate levels are monitored because hyperphosphataemia — common in CKD — often improves after transplant but can persist. Metabolic acidosis (low bicarbonate) may indicate graft dysfunction.

5. Liver Function Tests (LFTs)

Several immunosuppressive medications — including azathioprine and mTOR inhibitors — can cause hepatotoxicity. LFTs (ALT, AST, bilirubin, alkaline phosphatase) are monitored regularly. Abnormal LFTs may also indicate hepatitis B or C reactivation, which can occur when immunosuppression is intensified.

6. Fasting Blood Glucose and HbA1c — Screening for Post-Transplant Diabetes

Post-transplant diabetes mellitus (PTDM) affects up to 20–25% of kidney transplant recipients, driven primarily by corticosteroids and tacrolimus. Fasting glucose is checked frequently in the early post-transplant period, and HbA1c is measured at 3-monthly intervals. Early detection allows dietary modification, dose adjustment, or initiation of antidiabetic therapy before complications develop.

7. Lipid Profile — Cardiovascular Risk Management

Immunosuppressive drugs — especially corticosteroids, cyclosporine, and mTOR inhibitors — frequently cause dyslipidaemia. Annual fasting lipid panels guide statin therapy, which is recommended for most transplant recipients given their elevated cardiovascular risk. The cardiology team at Apex Hospitals works closely with the nephrology unit to manage cardiovascular risk in transplant patients.

8. CMV and BK Virus PCR — Viral Surveillance

Two viruses deserve special attention in the post-transplant period:

• Cytomegalovirus (CMV) PCR: CMV is the most common opportunistic infection after kidney transplant. CMV viraemia (virus detected in blood) is treated with antiviral therapy (valganciclovir). Untreated CMV can cause pneumonitis, colitis, retinitis, and graft injury.

• BK Virus PCR: BK virus can cause BK nephropathy — a major cause of late graft loss. Screening with plasma BK PCR is recommended monthly for the first 6 months and then quarterly up to 2 years. Rising BK levels prompt reduction in immunosuppression.

9. Donor-Specific Antibodies (DSA)

The development of new antibodies directed specifically against the donor's HLA antigens (de novo DSA) is a major predictor of chronic antibody-mediated rejection — the leading cause of late graft failure. DSA testing is performed at regular intervals (typically at 1, 3, 6, and 12 months, then annually) and whenever there is an unexplained rise in creatinine. A positive DSA result may prompt kidney biopsy and intensification of immunosuppression.

10. Uric Acid and Calcium

Hyperuricaemia (high uric acid) is common after transplant, partly due to calcineurin inhibitors reducing uric acid excretion. Gout can develop and requires careful management — many standard gout medications interact with immunosuppressants. Calcium and parathyroid hormone (PTH) levels are monitored because secondary hyperparathyroidism from CKD often persists after transplant (tertiary hyperparathyroidism), causing hypercalcaemia and bone disease.

How Often Are Blood Tests Done After a Kidney Transplant?

The monitoring schedule is most intensive in the first three months, when the risk of acute rejection is highest and immunosuppression doses are being adjusted. A typical protocol looks like this:

These are general guidelines; individual schedules are tailored by the transplant nephrologist based on the patient's clinical course, rejection history, and comorbidities. The nephrology specialists at Apex Hospitals provide personalised monitoring plans and are available for urgent review whenever results raise concern.

What Happens When a Blood Test Result Is Abnormal?

An abnormal result does not automatically mean rejection or graft failure — but it always requires prompt evaluation. The transplant team will consider the full clinical picture: symptoms, other laboratory values, medication adherence, and recent changes in health. Common responses include:

• Rising creatinine: Ultrasound to exclude obstruction, tacrolimus level check, possible kidney biopsy

• High tacrolimus level: Dose reduction, review for drug interactions (many common medications affect tacrolimus metabolism)

• Positive BK PCR: Reduction in immunosuppression, close monitoring

• CMV viraemia: Antiviral treatment with valganciclovir, dose adjusted for kidney function

• New DSA detected: Kidney biopsy, possible plasmapheresis and IVIG therapy

• High blood glucose: Dietary counselling, possible initiation of insulin or oral agents

The critical care and nephrology teams at Apex Hospitals work in close coordination to manage complex post-transplant complications, supported by on-site CT, MRI, and emergency laboratory services available around the clock.

Living With a Transplanted Kidney: The Long-Term Monitoring Mindset

Many patients feel well for years after a successful transplant — and that is precisely when the temptation to skip blood tests is strongest. But chronic rejection is often silent, progressing over months or years without obvious symptoms until significant graft damage has occurred. Consistent monitoring is the only reliable way to catch problems early, when intervention is most effective.

Beyond kidney-specific tests, transplant recipients also need regular screening for skin cancers (immunosuppression increases risk significantly), cervical cancer, and colorectal cancer. The oncology team at Apex Hospitals collaborates with the transplant unit to ensure comprehensive cancer surveillance for long-term recipients.

Bone health is another long-term concern. Corticosteroids and pre-existing hyperparathyroidism increase the risk of osteoporosis. Annual bone density scans and regular calcium, vitamin D, and PTH monitoring are part of a complete post-transplant care plan. The physiotherapy and rehabilitation team at Apex Hospitals supports transplant patients with weight-bearing exercise programmes that protect bone density and cardiovascular health.

Diet plays a meaningful role too. The dietetics and nutrition specialists at Apex Hospitals guide transplant patients on managing potassium, phosphate, sodium, and calorie intake — all of which affect blood test results and long-term graft health.

Kidney Transplant Care at Apex Hospitals, Jaipur

Apex Hospitals has been providing comprehensive kidney care in Rajasthan since 1994. The hospital's kidney transplant programme in Jaipur integrates pre-transplant evaluation, surgical expertise, and structured post-transplant monitoring under one roof. The on-site laboratory supports rapid turnaround of all critical transplant-related tests, including tacrolimus levels, DSA, and viral PCR panels. Advanced hemodialysis and CRRT machines are available for patients who require renal support before or after transplant.

The hospital is NABH accredited and empanelled under Ayushman Bharat, making transplant care accessible to a broader population across Rajasthan. The HOPE Tele-ICU Command Centre — featured in the Harvard Business Review — connects 18 partner sites across the state, extending specialist nephrology consultation to patients who cannot travel to Jaipur for every follow-up appointment.

If you or a family member is preparing for a kidney transplant evaluation, or if you are a transplant recipient with questions about your monitoring schedule, the nephrology team at Apex Hospitals is available for consultation at the Malviya Nagar campus in Jaipur.

Frequently Asked Questions

How long do I need to have blood tests after a kidney transplant?

Blood tests are required for life after a kidney transplant. The frequency decreases significantly over time — from daily in the first week to monthly or quarterly after the first year — but monitoring never stops entirely. Rejection and complications can occur years after transplant, and regular blood tests are the most reliable early warning system.

What is the most important blood test after a kidney transplant?

Serum creatinine is the primary marker of graft function and is checked at every monitoring visit. Tacrolimus drug levels are equally critical in the early post-transplant period. Over time, BK virus PCR and donor-specific antibody (DSA) testing become increasingly important for detecting late complications.

Can I have a kidney transplant if my blood type doesn't match the donor?

ABO-incompatible transplants are possible at specialised centres using desensitisation protocols — typically plasmapheresis and intravenous immunoglobulin (IVIG) — to reduce the recipient's antibodies against the donor blood type. These procedures carry higher risk and require careful patient selection. Your transplant team will advise whether you are a candidate.

What does a high tacrolimus level mean?

A tacrolimus level above the target range means the drug is accumulating in the blood, increasing the risk of toxicity — including kidney damage (nephrotoxicity), tremors, headache, and high blood pressure. The dose is usually reduced, and the level is rechecked within 48–72 hours. Many common medications and foods (including grapefruit) can raise tacrolimus levels by affecting its metabolism.

What is BK virus and why is it tested after transplant?

BK virus is a common virus that most people carry harmlessly. Under immunosuppression, it can reactivate and infect the transplanted kidney, causing BK nephropathy — a significant cause of graft loss. Plasma BK PCR testing detects the virus before it causes kidney damage. If detected, immunosuppression is carefully reduced to allow the immune system to control the virus.

Is the pre-transplant evaluation done for living donors too?

Yes — living kidney donors undergo an equally thorough evaluation to ensure they are healthy enough to donate and will not be harmed by living with one kidney. This includes blood typing, HLA typing, kidney function tests, metabolic screening, infectious disease testing, and cardiovascular assessment. Donor safety is the highest priority in any living donor programme.

References

1. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — Kidney Transplant

2. National Kidney Foundation — Transplantation

Have Questions About Your Kidney Transplant Journey?

The nephrology and transplant team at Apex Hospitals, Jaipur is here to guide you through every step — from your first evaluation blood test to lifelong follow-up care.

Learn About Our Kidney Transplant Programme